Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 14,975 | 4,179 | 0 | 0 | 0 |
| Cost of Goods | 3,383 | 562 | N/A | N/A | N/A |
| Gross Profit | 11,592 | 3,617 | N/A | N/A | N/A |
| Operating Expenses | 105,632 | 57,879 | 0 | 0 | 0 |
| Operating Income | -93,657 | -53,700 | N/A | N/A | N/A |
| Interest Expense | 9,272 | 4,592 | 0 | 0 | 0 |
| Other Income | 12,798 | 539 | 0 | 0 | 0 |
| Pre-tax Income | -90,131 | -57,753 | 0 | 0 | 0 |
| Income Tax | -644 | -11,244 | N/A | N/A | N/A |
| Net Income Continuous | -89,487 | -46,509 | N/A | N/A | N/A |
| Net Income Discontinuous | 4,018 | 3,584 | N/A | N/A | N/A |
| Net Income | $-85,469 | $-42,925 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -2.36 | -1.69 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -2.47 | -1.83 | N/A | N/A | N/A |
| EPS Basic Discontinuous Ops | 0.11 | 0.14 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2.36 | -1.69 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -2.47 | -1.83 | N/A | N/A | N/A |
| EPS Diluted Discontinuous Ops | 0.11 | 0.14 | N/A | N/A | N/A |
| EBITDA(a) | $-79,516 | $-50,638 | $N/A | $N/A | $N/A |